Skip to main content
. Author manuscript; available in PMC: 2019 Sep 16.
Published in final edited form as: Sex Transm Dis. 2012 Nov;39(11):877–879. doi: 10.1097/OLQ.0b013e3182685d2b

TABLE 1.

Characterization of Pre-treatment and Post-treatment N. gonorrhoeae Isolates From the Index Patient

Isolate mtrR Promoter Region Mutations Amino Acid Changes in Coding Region of MtrR 23S rRNA*
Allele 1 Allele 2 Allele 3 Allele 4
Pre-treatment P1101 Deletion of A No mutation C2599T mutation No mutation No mutation C2599T mutation
Post-treatment P1102 Deletion of A H105Y mutation C2599T mutation C2599T mutation C2599T mutation C2599T mutation
Susceptible control strain SC113 No mutation No mutation No mutation No mutation No mutation No mutation
*

23S rRNA N. gonorrhoeae numbering.

A indicates adenine; C, cytosine; T, thymine; H, histidine; Y, tyrosine.